Details for 2014775569

Up to date per 01.04.2026

Actions

Title / Product Name

7-BENZYL-10-(2-METHYLBENZYL)-2,6,7,8,9,10-HEXAHYDROIMIDAZO-[1,2-A]-PYRIDO-[4,3-D]-PYRIMIDIN-5-(3H)-ON ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014775569

EP Publication Number

2968294

E-Number

1125999

Language

PCT Number

US14025885

Publication Date

20.01.2016 A

01.05.2019 B1

Registration Date

01.05.2019

AT Publication Date

15.05.2019

Application Date

13.03.2014

Registration Number

Priorities

13.03.2013

201361779828 P

15.11.2013

201361904718 P

IPC

A61K 31/519 20060101AFI20181127BHEP

Maximum Duration of Protection

13.03.2034

Owner

Oncoceutics, Inc.3675 Market Street Suite 200 Philadelphia, PA 19104US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

STOGNIEW, Martin1870 Ferguson Ln. Blue Bell, PA 19422US

ALLEN, Joshua, E.129 Tremont St Cambridge, MA 02139US

NALLAGANCHU, Bhaskara, Rao99 Norstrand Road Hillsborough, NJ 08852US

POTTORF, Richard, S.7550 Prairie View Dr. Indianapolis, IN 46526US

OLSON, Gary, L.7 Deer Park Drive Suite D Monmouth Junction, NJ 08852US

Information about Fees